Skip to main content

Jankowski Jess's Form 4 filing

Solesence, Inc. (SLSN) · filed Oct 26, 2022

Accession no.
0001209191-22-054667
Filed
Oct 26, 2022, 6:06 PM ET
Trade date
Oct 24-25, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.75K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jankowski JessCIK 0001184478Director, Officer (President, CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 24, 2022Common StockMOption exerciseAcquired+2,500$0.415F1+$1,037.561,500Direct
Oct 24, 2022Common StockSSaleDisposed−2,500$2.35−$5,87559,000Direct
Oct 25, 2022Common StockMOption exerciseAcquired+800$0.415+$33259,800Direct
Oct 25, 2022Common StockSSaleDisposed−800$2.34−$1,87259,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 24, 2022Common StockMOption exerciseDisposed−90,000$0.415−$1,037.587,500Direct
Oct 25, 2022Common StockMOption exerciseDisposed−87,500$0.415−$33286,700Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.

Referenced by the price of 1 transaction in Table I.

Remarks

Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having shares from this grant sold, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. The maturity of these rights cannot be extended beyond the IRS statutory limit of ten years.

Read the full filing on SEC EDGAR (opens in a new tab)